Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
出版年份 2014 全文链接
标题
Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
作者
关键词
-
出版物
ONCOGENE
Volume 34, Issue 15, Pages 1919-1927
出版商
Springer Nature
发表日期
2014-06-02
DOI
10.1038/onc.2014.138
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling
- (2013) Susan Thrane et al. BREAST CANCER RESEARCH AND TREATMENT
- CDC25A targeting by miR-483-3p decreases CCND–CDK4/6 assembly and contributes to cell cycle arrest
- (2013) T Bertero et al. CELL DEATH AND DIFFERENTIATION
- Global characterization of signalling networks associated with tamoxifen resistance in breast cancer
- (2013) Brigid C. Browne et al. FEBS Journal
- NFκB signaling is important for growth of antiestrogen resistant breast cancer cells
- (2012) Christina W. Yde et al. BREAST CANCER RESEARCH AND TREATMENT
- Increased signalling of EGFR and IGF1R and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas
- (2012) A Gallardo et al. BRITISH JOURNAL OF CANCER
- Biological mechanisms and clinical implications of endocrine resistance in breast cancer
- (2011) Mario Giuliano et al. BREAST
- A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast Cancer
- (2011) E. M. Fox et al. CANCER RESEARCH
- Shorter disease-specific survival of ER-positive breast cancer patients with high cytoplasmic Src kinase expression after tamoxifen treatment
- (2011) B. Elsberger et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Mechanisms of Endocrine Resistance in Breast Cancer
- (2010) C. Kent Osborne et al. Annual Review of Medicine
- Fyn
- (2010) Yoshihito D. Saito et al. CANCER
- Elevated Src kinase activity attenuates tamoxifen response in vitro and is associated with poor prognosis clinically.
- (2010) Liam Morgan et al. CANCER BIOLOGY & THERAPY
- Advances in Targeting Src in the Treatment of Breast Cancer and Other Solid Malignancies
- (2010) E. L. Mayer et al. CLINICAL CANCER RESEARCH
- BCL2 and CASP8 regulation by NF-κB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells
- (2010) Ruchi Nehra et al. FASEB JOURNAL
- An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer
- (2009) Katrine L. Henriksen et al. ACTA ONCOLOGICA
- Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass Spectrometry
- (2009) Rikke Leth-Larsen et al. MOLECULAR & CELLULAR PROTEOMICS
- Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancer
- (2008) E J Campbell et al. BRITISH JOURNAL OF CANCER
- Genome-Wide Analysis of Aromatase Inhibitor-Resistant, Tamoxifen-Resistant, and Long-Term Estrogen-Deprived Cells Reveals a Role for Estrogen Receptor
- (2008) S. Masri et al. CANCER RESEARCH
- ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2
- (2008) S. Pancholi et al. ENDOCRINE-RELATED CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now